Neuroleptic Malignant Syndrome (NMS) is a rare but potentially life-threatening medical condition that may occur as a result of using certain medications, particularly antipsychotic drugs. It can affect the functioning of the nervous system, muscles, and the body's ability to regulate temperature.The severity of this condition lies in the fact that its symptoms can develop rapidly and may include a dangerously high body temperature, muscle rigidity, altered mental status, and changes in heart rate and blood pressure. Therefore, early recognition of symptoms and prompt medical intervention are essential to prevent serious complications.What are the causes of Neuroleptic Malignant Syndrome? What are its most common symptoms, and how can it be diagnosed, treated, and prevented? In this article from Dalili Medical, we explore the most important information you need to know about this condition.
1. What is Neuroleptic Malignant Syndrome?
Neuroleptic Malignant Syndrome (NMS) is a rare but serious medical condition that most commonly occurs as a result of using certain antipsychotic medications that affect dopamine activity in the brain. It is characterized by high body temperature, muscle rigidity, altered levels of consciousness, and dysfunction of the autonomic nervous system.
2. Is Neuroleptic Malignant Syndrome a psychiatric or neurological disorder?
Neuroleptic Malignant Syndrome is a neurological and medication-induced medical emergency rather than an independent psychiatric disorder, although it is commonly associated with medications used to treat psychiatric conditions.
3. Can Neuroleptic Malignant Syndrome be fatal?
Yes, Neuroleptic Malignant Syndrome can be fatal in severe cases, particularly when diagnosis and treatment are delayed. Serious complications may include rhabdomyolysis (muscle breakdown), kidney failure, cardiac arrhythmias, and respiratory failure. However, early diagnosis and prompt medical intervention significantly improve the chances of recovery and reduce the risk of complications.
4. Can Neuroleptic Malignant Syndrome cause a coma?
Yes, severe cases of Neuroleptic Malignant Syndrome may lead to coma due to dangerously elevated body temperature, nervous system dysfunction, and impaired vital organ function, particularly when appropriate treatment is not provided promptly.
5. Can Neuroleptic Malignant Syndrome cause high blood pressure?
Yes, Neuroleptic Malignant Syndrome can cause either high or low blood pressure, as well as significant fluctuations in blood pressure levels. This occurs due to dysfunction of the autonomic nervous system, which is responsible for regulating blood pressure and heart rate.
Neuroleptic Malignant Syndrome most commonly occurs due to disturbances in dopamine activity in the brain. It is primarily associated with the use of certain medications that block dopamine receptors or the sudden discontinuation of medications that increase dopamine activity.
The most common causes and contributing factors include:
1. Use of antipsychotic medications: This is the most common cause, particularly with first-generation (typical) antipsychotics, such as haloperidol and chlorpromazine. However, the syndrome can also occur with some second-generation (atypical) antipsychotics, including risperidone and olanzapine.
2. Taking high doses of medication: Using high doses of antipsychotic medications may increase the risk of developing Neuroleptic Malignant Syndrome.
3. Rapid dose escalation: Increasing the dose of antipsychotic medication over a short period without appropriate gradual adjustment may increase the risk of the condition.
4. Injectable antipsychotic medications: The administration of certain antipsychotic medications by injection, particularly long-acting injectable formulations, may be associated with an increased risk in some cases.
5. Combining multiple medications that affect dopamine: Taking several medications that influence dopamine activity or dopamine receptors may increase the likelihood of developing the syndrome.
6. Abrupt discontinuation of dopamine-enhancing medications: Neuroleptic Malignant Syndrome may develop after suddenly stopping certain medications used to treat Parkinson's disease, such as levodopa, due to a sharp reduction in dopamine activity in the brain.
In addition to medication-related causes, several factors may increase the risk of developing Neuroleptic Malignant Syndrome, particularly in individuals taking medications that affect dopamine activity. The most notable risk factors include:
Dehydration: Inadequate fluid intake, which may interfere with the body's ability to regulate essential physiological functions.
Severe physical exertion: Excessive physical activity or extreme fatigue.
Psychomotor agitation: Severe psychological distress or agitation accompanied by excessive physical activity.
Infections or acute illnesses: Severe physical illnesses may increase susceptibility to developing the syndrome.
Malnutrition: Inadequate intake of essential nutrients required for normal body functions.
Previous history of Neuroleptic Malignant Syndrome: A previous episode may increase the risk of recurrence when exposed to triggering medications again.
Underlying neurological disorders: Certain neurological conditions or brain injuries may be associated with an increased susceptibility to the syndrome.
Important Note: These factors do not necessarily cause Neuroleptic Malignant Syndrome on their own. However, they may increase the risk of developing the condition, particularly when combined with medications that affect dopamine activity.
Symptoms of Neuroleptic Malignant Syndrome usually develop within a short period after starting the triggering medication or increasing its dose. The condition can progress rapidly into a serious medical emergency requiring immediate intervention.
The most common symptoms include:
1. High Body Temperature (Hyperthermia): Body temperature may rise to dangerously high levels, making this one of the characteristic features of the syndrome.
2. Muscle Rigidity: Severe muscle stiffness may occur, sometimes accompanied by pain and difficulty moving the limbs and other parts of the body.
3. Altered Mental Status and Level of Consciousness: Patients may experience confusion, disorientation, or delirium. In severe cases, this may progress to reduced consciousness or coma.
4. Excessive Sweating (Diaphoresis): This occurs due to dysfunction of the autonomic nervous system, which regulates body temperature and sweating.
5. Rapid Heart Rate (Tachycardia): The heart rate may increase significantly due to autonomic nervous system dysfunction and the systemic effects of the syndrome.
6. Blood Pressure Changes: Patients may experience high or low blood pressure, as well as sudden and repeated fluctuations in blood pressure levels.
7. Rapid Breathing (Tachypnea): The respiratory rate may increase due to elevated body temperature, severe physical stress, and disturbances in vital body functions.
8. Tremors: Involuntary shaking or trembling may occur throughout the body and may accompany muscle rigidity.
9. Difficulty Swallowing (Dysphagia): Patients may have difficulty swallowing food or liquids due to the involvement of muscles responsible for swallowing.
10. Urinary Control Problems: Some patients may experience urinary incontinence or difficulty controlling urination.
11. Speech Difficulties: Patients may experience slowed speech or difficulty speaking and communicating due to muscle rigidity or changes in neurological and mental function.
12. Excessive Salivation: Increased saliva production or difficulty controlling saliva may occur due to impaired swallowing function.
13. Seizures: Seizures may develop in some cases, particularly when neurological complications or severe disturbances in body functions occur.
14. Cardiac Arrhythmias: Irregular heart rhythms may develop due to autonomic nervous system dysfunction or imbalances in electrolytes and other essential body functions, potentially increasing the severity of the condition.
Neuroleptic Malignant Syndrome (NMS) is associated with the use of certain medications that affect dopamine activity in the brain. Antipsychotic medications are among the most commonly implicated drugs. However, in rare cases, the condition may also develop with certain other medications or following the sudden discontinuation of drugs that increase dopamine activity.
The following are the main categories of medications associated with Neuroleptic Malignant Syndrome:
These medications are among the drugs most commonly associated with Neuroleptic Malignant Syndrome, particularly those that strongly block dopamine receptors. Examples include:
Haloperidol.
Chlorpromazine.
Fluphenazine.
Flupentixol.
Perphenazine.
Zuclopenthixol.
Second-generation antipsychotics can also cause Neuroleptic Malignant Syndrome, although the likelihood of developing the condition varies depending on the medication, dosage, and patient's overall health. Examples include:
Risperidone.
Olanzapine.
Quetiapine.
Clozapine.
Aripiprazole.
Ziprasidone.
Paliperidone.
Some antiemetic medications may also trigger Neuroleptic Malignant Syndrome because of their effects on dopamine receptors. These include:
Metoclopramide.
Prochlorperazine.
Droperidol.
Rare cases of Neuroleptic Malignant Syndrome have been reported in association with certain other medications, particularly when they are taken alongside antipsychotics or when additional risk factors are present. These medications include:
Lithium: Used to treat bipolar disorder.
Amoxapine: An antidepressant medication.
Reserpine: A medication that affects the levels of certain neurotransmitters.
Neuroleptic Malignant Syndrome is not only associated with taking certain medications. It may also develop following the sudden discontinuation of medications that enhance dopamine activity in the brain, particularly those used to treat Parkinson's disease.
Examples include:
Levodopa.
Amantadine.
Tolcapone.
Certain dopamine agonists used in the treatment of Parkinson's disease.
Important: These medications should never be started, stopped, or adjusted without medical supervision. Sudden discontinuation of Parkinson's disease medications can trigger a potentially life-threatening condition resembling Neuroleptic Malignant Syndrome, known as parkinsonism-hyperpyrexia syndrome.
The diagnosis of Neuroleptic Malignant Syndrome (NMS) depends on evaluating the patient's symptoms and clinical signs, reviewing their medical history and current medications, and performing a series of laboratory tests and medical investigations to assess the effects of the syndrome on the muscles and vital organs. These tests also help identify potential complications and rule out other medical conditions that may present with similar symptoms.
The main methods used to diagnose Neuroleptic Malignant Syndrome include:
The doctor begins by assessing the patient's overall health, identifying their symptoms, and reviewing their medical history and current medications, particularly antipsychotic drugs and other medications that affect dopamine activity in the brain.
The clinical examination includes:
Measuring body temperature: To identify hyperthermia, which is one of the characteristic signs of the syndrome.
Muscle examination: To check for severe muscle rigidity or stiffness in the limbs.
Assessing the level of consciousness: To identify confusion, disorientation, delirium, or reduced consciousness.
Measuring blood pressure: To detect high or low blood pressure or sudden fluctuations in blood pressure levels.
Measuring heart rate: To identify tachycardia or irregular heart rhythms.
Assessing respiratory rate: To check for rapid or difficult breathing.
Neurological examination: To evaluate movement, muscle strength, responses to stimuli, and neurological reflexes.
Blood tests help detect the effects of Neuroleptic Malignant Syndrome on the muscles, kidneys, liver, and other organs. They also help identify potential complications.
The most important blood tests include:
1. Creatine Kinase (CK) Test: This is one of the most important laboratory tests used to support the diagnosis. CK levels increase as a result of muscle fiber breakdown and may become extremely elevated in severe cases.
2. Complete Blood Count (CBC): This test may reveal an increased white blood cell count, which is one of the laboratory abnormalities that can accompany the syndrome.
3. Kidney Function Tests: These include measuring creatinine and urea levels to detect kidney damage resulting from muscle breakdown and the accumulation of myoglobin.
4. Electrolyte and Mineral Tests: These tests help identify abnormalities in sodium, potassium, calcium, and other essential minerals, particularly when severe muscle breakdown occurs.
5. Liver Function Tests: These help assess potential liver involvement and complications associated with the syndrome.
6. Coagulation Tests: These may be performed when clotting abnormalities are suspected, particularly in severe cases that may be complicated by disseminated intravascular coagulation (DIC).
The doctor may request a urine test to detect the presence of myoglobin, a protein released into the bloodstream when muscle fibers break down. Its presence in the urine may cause the urine to become dark-colored.
This test helps identify rhabdomyolysis and assess the risk of kidney complications, particularly acute kidney injury.
An electrocardiogram is used to detect abnormalities in heart rate and rhythm, particularly when potassium levels change or electrolyte imbalances develop as a result of muscle breakdown.
It also helps monitor the potential effects of the syndrome on cardiac function.
Depending on the patient's symptoms and medical condition, the doctor may request additional tests, including:
Blood Gas Analysis: To assess blood acidity, oxygen levels, and carbon dioxide levels.
Blood or Urine Cultures: To detect bacterial infections when an underlying infection is suspected.
Brain CT Scan: To rule out certain neurological conditions that may cause altered consciousness or similar symptoms.
Brain MRI: This may be used when further assessment of neurological abnormalities is needed or when other conditions affecting the brain must be excluded.
Several medical conditions may produce symptoms similar to Neuroleptic Malignant Syndrome, particularly high body temperature, muscle rigidity, and altered consciousness. Therefore, doctors must distinguish between these conditions before confirming the diagnosis.
The most important conditions include:
Serotonin Syndrome: This usually develops as a result of taking medications that increase serotonin activity in the brain. It may cause hyperthermia, excessive sweating, and altered mental status. However, it is often distinguished by increased reflexes (hyperreflexia) and muscle clonus.
Heat Stroke: This condition can cause dangerously high body temperature and altered consciousness due to exposure to excessive heat.
Encephalitis or Meningitis: These conditions may cause fever, confusion, and neurological disturbances, sometimes accompanied by neck stiffness or other neurological symptoms.
Thyroid Storm: This is a severe complication of hyperthyroidism that may cause high body temperature, rapid heart rate, agitation, and altered consciousness.
Other Drug Reactions: Certain medication-related reactions may produce similar symptoms, including muscle rigidity, altered consciousness, and elevated body temperature.
Doctors use several established medical criteria to help confirm the diagnosis. The most notable include:
Diagnostic and Statistical Manual of Mental Disorders (DSM-5) Criteria: These include a combination of clinical features associated with exposure to dopamine-blocking medications, such as elevated body temperature, muscle rigidity, changes in mental status, and autonomic nervous system dysfunction, alongside appropriate investigations to exclude other causes.
International Consensus Criteria: These rely on evaluating a combination of clinical and laboratory findings, including exposure to medications associated with the syndrome, elevated body temperature, muscle rigidity, increased creatine kinase levels, and autonomic nervous system abnormalities.
Neuroleptic Malignant Syndrome is a serious medical condition that can lead to life-threatening complications, particularly when diagnosis is delayed or appropriate treatment is not provided. These complications result from dangerously elevated body temperature, severe muscle rigidity, muscle fiber breakdown, and disturbances in the nervous system and vital organ functions.
The most important risks and complications of Neuroleptic Malignant Syndrome include:
Rhabdomyolysis is one of the most serious complications of Neuroleptic Malignant Syndrome. It occurs as a result of severe muscle rigidity and damage to muscle fibers, causing substances and proteins, such as myoglobin and creatine kinase, to be released into the bloodstream.
The accumulation of these substances may damage kidney function and increase the risk of acute kidney injury.
The release of myoglobin from damaged muscle fibers may cause it to accumulate in the kidneys, damaging kidney tissues and reducing their ability to filter the blood and eliminate waste products and excess fluids.
Severe cases may require urgent medical intervention.
Severe fluctuations in blood pressure and electrolyte imbalances, particularly abnormal potassium levels, may interfere with the heart's electrical activity.
This can lead to irregular heart rhythms (cardiac arrhythmias) and, in severe cases, may result in cardiac arrest.
Severe muscle rigidity may affect the muscles responsible for breathing. Additionally, reduced consciousness may impair the patient's ability to protect their airway.
This can result in breathing difficulties, low blood oxygen levels, and, in advanced cases, respiratory failure.
Neuroleptic Malignant Syndrome may affect nervous system function, leading to symptoms such as confusion, delirium, impaired perception, and difficulty concentrating.
In severe cases, these symptoms may progress to reduced consciousness, complete loss of consciousness, or coma.
Severe cases of Neuroleptic Malignant Syndrome may lead to disseminated intravascular coagulation, a serious condition involving abnormal activation of the blood-clotting process.
This results in the formation of small blood clots within blood vessels, while clotting factors are consumed, increasing the risk of bleeding in different parts of the body.
Patients may develop aspiration pneumonia due to swallowing difficulties, which can cause food or liquids to enter the respiratory tract instead of the esophagus.
The risk of other respiratory infections may also increase due to the patient's weakened overall condition or prolonged hospitalization.
Severe muscle rigidity, reduced mobility, and prolonged bed rest may increase the risk of blood clots forming in the deep veins, particularly those in the legs.
These clots may travel to the lungs, causing a pulmonary embolism, which is a serious medical emergency requiring immediate treatment.
In advanced cases, the combined complications of Neuroleptic Malignant Syndrome may affect several vital organs simultaneously, including the heart, kidneys, liver, and lungs.
This may result in multiple organ dysfunction or failure, potentially threatening the patient's life.
Death is the most serious potential complication of Neuroleptic Malignant Syndrome. It may occur as a result of severe complications, such as respiratory failure, acute kidney injury, cardiac abnormalities, or disseminated intravascular coagulation, particularly when diagnosis and treatment are delayed.
Important Medical Note: Despite the seriousness of Neuroleptic Malignant Syndrome, early diagnosis and immediate treatment in a hospital can significantly reduce the risk of complications and improve the chances of recovery. Therefore, symptoms such as dangerously high body temperature, severe muscle rigidity, and altered consciousness require immediate emergency medical attention.
Treatment of Neuroleptic Malignant Syndrome (NMS) depends on how quickly medical intervention is initiated, the severity of symptoms, and the extent to which vital organs are affected by complications. The goals of treatment are to eliminate the effects of the causative medication, control elevated body temperature and muscle rigidity, restore dopamine activity in the brain, and prevent potential complications.
Treatment must take place in a hospital. Severe cases may require intensive care and continuous monitoring. The main medications and therapeutic interventions include:
The first step in treatment is the immediate discontinuation of the medication suspected of causing the syndrome, particularly antipsychotics and other medications that suppress dopamine activity.
The physician also reviews all medications the patient is taking to identify potential drug interactions and determine which medications should be discontinued or adjusted.
The causative medication should not be restarted unless a specialist has carefully assessed the patient and evaluated the potential risks and benefits.
The physician may prescribe certain medications to help reduce severe muscle rigidity and spasms, as well as limit heat production caused by excessive muscle activity. The most commonly used options include:
Dantrolene: Acts directly on the muscles and helps reduce muscle spasms, rigidity, and heat production resulting from excessive muscle activity. It may be used in some moderate to severe cases.
Benzodiazepines: Such as lorazepam, which help relieve agitation and muscle tension. They may be used in less severe cases or as adjunctive treatment.
The physician may use medications that enhance dopamine activity in the brain, particularly in moderate to severe cases. These include:
Bromocriptine: Acts as a dopamine receptor agonist, helping enhance dopamine activity in the brain and potentially relieve symptoms of the syndrome.
Amantadine: Helps increase dopamine activity in the brain and may be used as an alternative to bromocriptine or in selected cases, depending on the physician's assessment.
Patients may require additional medications and therapeutic interventions to manage symptoms and complications associated with the syndrome, including:
Antihypertensive medications: Used when severe hypertension occurs. The appropriate medication is selected according to the patient's condition, with careful monitoring of blood pressure fluctuations.
Medications to control heart rate and rhythm: May be used if cardiac arrhythmias develop, depending on the type and underlying cause of the rhythm disturbance.
Anticonvulsants: Used if seizures occur, to help control them and prevent recurrence.
Medications to correct electrolyte imbalances: Used to treat abnormally low or high levels of electrolytes and minerals in the blood, particularly potassium, sodium, and calcium.
Intravenous fluids: Help replace lost fluids, treat dehydration, maintain blood flow to the kidneys, and reduce the risk of kidney failure associated with muscle breakdown.
There is no conventional surgical treatment for Neuroleptic Malignant Syndrome because it is a medication-related neurological and medical condition that does not generally require surgery. However, physicians may consider certain advanced medical interventions in severe cases, particularly when the patient does not respond to medication or develops life-threatening complications.
One of the most notable interventions is electroconvulsive therapy, along with medical procedures used to manage serious complications.
Electroconvulsive therapy is one of the treatment options that may be considered in selected cases of Neuroleptic Malignant Syndrome, particularly severe or persistent cases that do not respond adequately to medication and supportive care.
This procedure involves delivering a controlled electrical current through electrodes placed on the scalp to induce a brief, medically controlled seizure in the brain. It is performed under general anesthesia, with the use of muscle-relaxing medication.
How Is Electroconvulsive Therapy Performed?
The patient undergoes a comprehensive medical assessment to determine whether the procedure is appropriate for their health condition.
The patient receives short-acting general anesthesia, along with a muscle relaxant.
Electrodes are placed on the scalp according to the treatment technique selected by the physician.
A controlled electrical current is delivered briefly to induce a therapeutic seizure.
Brain activity, heart function, breathing, and oxygen levels are monitored throughout the procedure.
The patient is transferred to the recovery room, where medical staff monitor the return of consciousness and ensure that vital signs remain stable.
When Is Electroconvulsive Therapy Used?
When the patient does not respond adequately to appropriate medication.
When severe symptoms persist despite discontinuation of the causative medication and the provision of supportive medical care.
When severe accompanying psychiatric symptoms warrant this type of treatment.
In selected cases where specialized medications cannot be used or do not produce the required therapeutic response.
Important Considerations About the Procedure:
Electroconvulsive therapy is not a surgical operation and does not require opening the skull or making a surgical incision.
The patient may require several sessions, depending on the severity of the condition and the response to treatment.
The patient's overall health must be assessed, and cardiac function, electrolyte levels, and potassium levels should be monitored before the procedure. The risks associated with anesthesia and muscle-relaxing medications must also be considered, particularly when rhabdomyolysis is present.
Electroconvulsive therapy is not routinely used in all patients with the syndrome. The physician determines whether it is necessary based on the individual patient's condition.
Although these procedures do not directly treat Neuroleptic Malignant Syndrome, they may be essential to saving the patient's life and managing complications caused by the condition.
The patient may require mechanical ventilation if respiratory failure develops or consciousness becomes so impaired that the patient cannot breathe adequately or protect their airway.
How Is Mechanical Ventilation Performed?
The medical team assesses the patient's ability to breathe independently and maintain a clear airway.
Anesthetic medications and muscle relaxants are administered when necessary.
A breathing tube is inserted through the mouth into the trachea.
The tube is connected to a mechanical ventilator, which supplies oxygen and supports breathing.
Oxygen levels, respiratory rate, and lung function are continuously monitored until the patient's condition stabilizes.
The patient may require dialysis if rhabdomyolysis causes severe acute kidney injury, particularly when waste products accumulate or serious fluid and electrolyte imbalances develop that cannot be managed with conventional treatment.
How Is Dialysis Performed?
Kidney function, electrolyte levels, and fluid balance are assessed.
A special dialysis catheter is inserted into a vein when necessary.
The patient is connected to the dialysis machine.
Blood is passed through a specialized filter to remove waste products and excess fluid and correct certain electrolyte imbalances.
Kidney function is monitored, and the need for additional dialysis sessions is determined according to the patient's response.
Severe cases may require admission to the intensive care unit for continuous monitoring of body functions and vital organs, particularly when cardiac, respiratory, or kidney complications develop.
Intensive care may include:
Continuous monitoring of body temperature, blood pressure, heart rate, and respiratory rate.
Administration of intravenous fluids to replace fluid losses and maintain kidney function.
Use of external cooling measures to control elevated body temperature.
Correction of electrolyte and mineral imbalances in the blood.
Monitoring of heart, kidney, and liver function.
Respiratory support when necessary.
Treatment of associated complications, such as rhabdomyolysis and cardiac arrhythmias.
What's your complaint?